Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €102.53 EUR
Change Today -2.38 / -2.27%
Volume 0.0
LAB On Other Exchanges
Symbol
Exchange
New York
As of 5:59 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

laboratory crp of amer hldgs (LAB) Snapshot

Open
€102.66
Previous Close
€104.91
Day High
€102.67
Day Low
€102.08
52 Week High
03/31/15 - €120.46
52 Week Low
10/15/14 - €75.30
Market Cap
10.4B
Average Volume 10 Days
5.4
EPS TTM
--
Shares Outstanding
101.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for LABORATORY CRP OF AMER HLDGS (LAB)

laboratory crp of amer hldgs (LAB) Related Businessweek News

No Related Businessweek News Found

laboratory crp of amer hldgs (LAB) Details

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of diseases. It also provides specialty testing services in the areas of allergy, clinical trials, diagnostic genetics, women's health, cardiovascular disease, identity, forensics, infectious disease, endocrinology, oncology, coagulation, occupational testing, and pain management. In addition, the company offers a range of early-stage and late-stage drug development services to the pharmaceutical and biotechnology industries, as well as laboratory testing services to the chemical, agrochemical, and food industries. Further, it operates an esoteric laboratory focused on personalized diagnostics for cardiovascular and metabolic disorders; and provides specialized forensic DNA analysis, proprietary DNA collection products, and relationship testing. The company provides its testing services through a sales force to the physicians, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories. Laboratory Corporation of America Holdings has collaboration with university, hospital and academic institutions, such as Duke University, The Johns Hopkins University, the University of Minnesota, and Yale University to license and commercialize new diagnostic tests. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

36,000 Employees
Last Reported Date: 02/26/15
Founded in 1971

laboratory crp of amer hldgs (LAB) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.0M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $338.5K
Executive Vice President and Chief Executive ...
Total Annual Compensation: $632.6K
Chief Legal Officer, Chief Compliance Officer...
Total Annual Compensation: $436.1K
Senior Vice President and Chief Medical Offic...
Total Annual Compensation: $352.2K
Compensation as of Fiscal Year 2014.

laboratory crp of amer hldgs (LAB) Key Developments

Laboratory Corporation of America Holdings Secures Multi-Year Agreement for Use of Xcellerate Platform in Worldwide Clinical Trials Portfolio

Laboratory Corporation of America Holdings announced that it has secured a multi-year agreement from a pharmaceutical company to use Covance Drug Development's Xcellerate platform as an exclusive central monitoring solution for their worldwide clinical trials portfolio. Xcellerate Clinical Trial Optimization suite is a proprietary, technology-enabled solution set, designed and proven to help biopharmaceutical companies meaningfully reduce the cost, time, complexity and risk associated with clinical trials. As part of this platform, which also includes Xcellerate forecasting & site selection, Xcellerate Trial Management and Xcellerate Insights, Xcellerate Monitoring helps clients proactively identify and mitigate clinical trial risks in near real time for a single study or across an entire portfolio of trials. Xcellerate Monitoring helps clients proactively identify and mitigate clinical trial risks in near real time for a single study or across an entire portfolio of trials as well as centralizes and consolidates all clinical trial data, enhances patient safety, improves trial efficiency and proactively enables clients to identify and mitigate potential risks.

Immunotec Limited Files Suit Against Qiagen N.V., Qiagen Inc., Quest Diagnostics and Laboratory Corporation of America Holdings

On August 10, 2015, Oxford Immunotec Limited filed suit in the United States District Court for the District of Massachusetts against Qiagen N.V., Qiagen Inc., Quest Diagnostics LLC, and Laboratory Corporation of America Holdings alleging claims of patent infringement. The defendants manufacture, sell and/or use the QuantiFERON-TB Gold In-Tube Test, an in vitro diagnostic test for the detection of TB infection.

Laboratory Corporation of America Holdings Announces Management Changes for Covance Drug Development (Covance)

Laboratory Corporation of America Holdings announced that Deborah Keller will succeed Joseph Herring as Chief Executive Officer of Covance Drug Development (Covance). Mr. Herring will retire on July 31 after more than a decade as CEO. Ms. Keller joined Covance in 1987 and has held senior leadership roles in global operations, quality assurance, and marketing over her tenure. Most recently she served as Executive Vice President, Covance and Group President, R&D Laboratories. As CEO of Covance, Ms. Keller will also be a member of the LabCorp Executive Committee and will report to David P. King, Chairman and CEO of LabCorp.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LAB:GR €102.53 EUR -2.38

LAB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cerner Corp $61.76 USD -1.37
Hologic Inc $38.81 USD -0.95
PAREXEL International Corp $65.72 USD -1.77
Quest Diagnostics Inc $67.80 USD -1.09
Sonic Healthcare Ltd A$20.18 AUD -0.54
View Industry Companies
 

Industry Analysis

LAB

Industry Average

Valuation LAB Industry Range
Price/Earnings 25.9x
Price/Sales 1.7x
Price/Book 2.5x
Price/Cash Flow 22.4x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABORATORY CRP OF AMER HLDGS, please visit www.labcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.